Bio-Works Technologies AB Stock
Equities
BIOWKS
SE0007387089
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 SEK | -4.96% | -5.96% | -62.25% |
Sales 2022 | 41.32M 3.81M | Sales 2023 | 43.9M 4.05M | Capitalization | 277M 25.53M |
---|---|---|---|---|---|
Net income 2022 | -45M -4.15M | Net income 2023 | -56M -5.16M | EV / Sales 2022 | 16.2 x |
Net cash position 2022 | 65.88M 6.08M | Net cash position 2023 | 39.38M 3.63M | EV / Sales 2023 | 5.41 x |
P/E ratio 2022 |
-16.4
x | P/E ratio 2023 |
-4.51
x | Employees | 36 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.22% |
1 day | -4.96% | ||
1 week | -5.96% | ||
Current month | -8.84% | ||
1 month | -33.00% | ||
3 months | -56.49% | ||
6 months | -60.59% | ||
Current year | -62.25% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Royce
CEO | Chief Executive Officer | 47 | 20-06-25 |
Founder | - | 05-12-31 | |
Arne Hauge
DFI | Director of Finance/CFO | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | 71 | 13-09-23 | |
Johan Sedihn
BRD | Director/Board Member | 59 | 20-05-14 |
Peter Nählstedt
BRD | Director/Board Member | 50 | 20-05-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.68 | -4.96% | 24,978 |
24-05-08 | 2.82 | -4.08% | 17,081 |
24-05-07 | 2.94 | +5.00% | 15,640 |
24-05-06 | 2.8 | -1.75% | 5,367 |
24-05-03 | 2.85 | -4.04% | 4,158 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 10:59 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-62.25% | 9.64M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- BIOWKS Stock